CYP2C19*2 status in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Laska, Amanda J; Han, Marie J; Lospinoso, Josh A; Brown, Patrick J; Beachkofsky, Thomas M

Laska, Amanda J; Han, Marie J; Lospinoso, Josh A; Brown, Patrick J; Beachkofsky, Thomas M.

Afiliação

Laska AJ; Department of Dermatology, San Antonio Uniformed Services Health Education Consortium, San Antonio, TX.
Han MJ; Department of Dermatology, San Antonio Uniformed Services Health Education Consortium, San Antonio, TX.
Lospinoso JA; 780th Military Intelligence Brigade, Ft Meade, MD, USA.
Brown PJ; Department of Dermatology, San Antonio Uniformed Services Health Education Consortium, San Antonio, TX.
Beachkofsky TM; Department of Dermatology, San Antonio Uniformed Services Health Education Consortium, San Antonio, TX.

Pharmgenomics Pers Med ; 10: 183-186, 2017.

Article em En | MEDLINE | ID: mdl-28553132

Palavras-chave

adverse events; dermatology; drug metabolism; drug reactions

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Pharmgenomics Pers Med Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google